Revance Therapeutics Drops on Missed Late Stage Results
Revance Therapeutics hit a new 52-week low in Tuesday’s session following the release of its late stage trial results.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 208
Why Infinity Pharmaceuticals Crashed
Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still way down on the day for other reasons.
Zimmer Biomet Prices Secondary Offering
Zimmer Biomet saw its shares slide in Tuesday's session after the company announced the pricing of its previously disclosed underwritten secondary offering.
Pfizer and Shire Move on IBD License Agreement
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
PointClickCare Prepares for IPO
PointClickCare has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Global Blood Therapeutics Sinks on Secondary Offering
Global Blood Therapeutics has filed with the SEC regarding a secondary offering valued up to $100 million.
MEDNAX Moves to Acquire Cardon
Mednax has announced that it will acquire Cardon Outreach, one of the nation's largest providers of integraded revenue cycle management services.
Why Marinus Pharmaceuticals Shares Are Sliding
Shares of Marinus Pharmaceuticals tumbled Monday morning after the company gave an update on top-line results from a Phase 3 clinical trial.
Why Eleven Biotherapeutics Is Making a Run
Eleven Biotherapeutics watched its shares climb early on Monday morning following a key FDA submission.
Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference
The Jefferies Healthcare Conference wrapped up in New York City last week, and the mood was reported as generally positive, with investors feeling much better than a few months ago.
7 Biopharma Companies That Destroyed Shareholders Last Week
Biotech companies that lost their way last week truly burned shareholders, whether it was due to ASCO, earnings or even unfavorable clinical trial updates.
The Fattest States In America
First Lady Michelle Obama launched her “Let’s Move” campaign against childhood obesity in 2010. The campaign aimed to “solve the challenge of childhood obesity within a generation.” The first five years of that campaign…
3 Biotechs That Just Announced Successful Phase 2 Trials
Here are three biotechs that just recently announced successful Phase 2 trial data for drugs with very big addressable markets.
Sophiris Soars on Positive Phase 2 Results
Sophiris Bio shares absolutely skyrocketed on Friday following positive results from its Phase 2a proof of concept study of topsalysin in localized prostate cancer.
Merck Moves to Acquire Afferent Pharma
Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.